Platinum Industries FY26 PAT Rises 3.7%; Management Targets 40%+ Growth in FY27
Platinum Industries reported FY26 consolidated PAT of Rs. 512.30 Mn (+3.70% YoY) and Q4 FY26 consolidated revenue of Rs. 1,320.10 Mn (+36.80% YoY). In its post-earnings conference call, management highlighted CPVC revenues of ~INR 110 crore in FY26, the launch of oleo chemicals sales in April targeting INR 55–60 crore this year, and Egypt plant commercialization expected in Q3 FY27 with peak revenue potential exceeding INR 600 crore. The company targets over 40% revenue growth in FY27 and a 35% CAGR through FY29, with EBITDA margins guided at 13%–15%.
*this image is generated using AI for illustrative purposes only.
Platinum Industries Limited has published its audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, in newspapers pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were published on May 14, 2026, in Financial Express (All editions) and Loksatta (Mumbai edition). The Board of Directors had approved the audited results during a meeting on May 12, 2026. Subsequently, the company held a Post Earnings Conference Call on May 13, 2026, where Chairman and Managing Director Mr. Krishna Dushyant Rana and CFO Mr. Ashok Bothra discussed the financial performance and strategic outlook.
The company reported a consolidated profit after tax (PAT) of Rs. 512.30 million for FY26, a 3.70% increase from Rs. 493.90 million in the previous year. Q4 FY26 consolidated PAT surged 164.80% year-on-year to Rs. 148.40 million. The statutory auditors carried out an audit of the results with a modified opinion for the quarter and year ended March 31, 2026.
Consolidated Financial Performance
The company delivered a robust performance in Q4 FY26, with consolidated revenue from operations growing 36.80% year-on-year to Rs. 1,320.10 million. EBITDA improved to Rs. 153.10 million from Rs. 78.60 million in the year-ago period, with the EBITDA margin expanding to 11.60% from 8.10%. For the full year, consolidated revenue rose 14.80% to Rs. 4,504.40 million, while EBITDA stood at Rs. 598.50 million against Rs. 574.30 million in FY25.
| Metric (Amounts in Mn): | Q4 FY26 | Q3 FY26 | Q4 FY25 | YoY% | QoQ% | FY26 | FY25 | YoY% |
|---|---|---|---|---|---|---|---|---|
| Revenue From Operations: | 1,320.10 | 1,046.70 | 965.10 | 36.80 | 26.10 | 4,504.40 | 3,922.60 | 14.80 |
| Gross Profit: | 399.80 | 330.00 | 255.10 | 56.80 | 21.20 | 1,344.60 | 1,175.90 | 14.30 |
| Gross Margin (%): | 30.30% | 31.50% | 26.40% | — | — | 29.90% | 30.00% | — |
| EBITDA: | 153.10 | 157.90 | 78.60 | 95.00 | -3.00 | 598.50 | 574.30 | 4.20 |
| EBITDA Margin (%): | 11.60% | 15.10% | 8.10% | — | — | 13.30% | 14.60% | — |
| Profit Before Tax (After Exceptional): | 165.00 | 167.90 | 83.80 | 96.90 | -1.70 | 658.90 | 674.30 | -2.30 |
| Profit After Tax: | 148.40 | 123.30 | 56.00 | 164.80 | 20.40 | 512.30 | 493.90 | 3.70 |
| PAT Margin (%): | 11.20% | 11.80% | 5.80% | — | — | 11.40% | 12.60% | — |
| Basic EPS (Rs.): | 2.75 | 2.29 | 1.03 | 167.00 | 20.10 | 9.46 | 8.94 | 5.80 |
Standalone Financial Performance
On a standalone basis, Platinum Industries reported strong growth across all key metrics. Q4 FY26 standalone revenue from operations rose 60.40% year-on-year to Rs. 1,319.90 million, while PAT grew 151.90% to Rs. 159.50 million. For the full year, standalone revenue increased 33.70% to Rs. 4,343.60 million, and PAT rose 9.60% to Rs. 535.30 million. The standalone EBITDA for FY26 stood at Rs. 602.30 million, with an EBITDA margin of 13.90%.
| Metric (Amounts in Mn): | Q4 FY26 | Q3 FY26 | Q4 FY25 | YoY% | QoQ% | FY26 | FY25 | YoY% |
|---|---|---|---|---|---|---|---|---|
| Revenue From Operations: | 1,319.90 | 1,026.20 | 822.70 | 60.40 | 28.60 | 4,343.60 | 3,248.90 | 33.70 |
| Gross Profit: | 398.00 | 317.20 | 233.80 | 70.30 | 25.50 | 1,289.80 | 1,066.70 | 20.90 |
| Gross Margin (%): | 30.20% | 30.90% | 28.40% | — | — | 29.70% | 32.80% | — |
| EBITDA: | 161.20 | 162.50 | 84.20 | 91.50 | -0.80 | 602.30 | 547.60 | 10.00 |
| EBITDA Margin (%): | 12.20% | 15.80% | 10.20% | — | — | 13.90% | 16.90% | — |
| Profit Before Tax: | 178.90 | 175.40 | 90.70 | 97.30 | 2.00 | 684.60 | 663.30 | 3.20 |
| Profit After Tax: | 159.50 | 129.30 | 63.30 | 151.90 | 23.40 | 535.30 | 488.40 | 9.60 |
| PAT Margin (%): | 12.10% | 12.60% | 7.70% | — | — | 12.30% | 15.00% | — |
| Basic EPS (Rs.): | 2.90 | 2.35 | 1.15 | 152.20 | 23.40 | 9.75 | 8.89 | 9.70 |
Business Segment Highlights
During the earnings call, management highlighted that CPVC contributed approximately 30% of consolidated revenue in FY26, with CPVC revenues at around INR 110 crore out of INR 450 crore. Monthly CPVC revenues range between INR 10 crore and INR 15 crore. CPVC gross margins have improved from 6%–7% when the segment was launched to 18%–20% currently, with potential to rise further to 22% as the product mix matures. The Q4 FY26 performance was driven by improved product mix and sustained demand in the PVC and CPVC pipe and fitting segment, aided by India's infrastructure development and urbanization trends. Management noted that PVC sales were slightly lower than the prior year, but CPVC growth offset this softness. The company has secured Supreme Industries and Prince Pipe and Fittings as major CPVC customers and is NSF approved, meeting American quality standards.
On the new oleo chemicals vertical, branded as Platinum Oleo Chemicals, the company commenced its first sales in April under a CDMO (Contract Development and Manufacturing Organization) model, targeting revenues of INR 55 crore to INR 60 crore for the year. Management indicated the company is simultaneously designing a dedicated manufacturing plant for oleo-based derivatives, expected to be operational within approximately one and a half years. The oleo chemicals segment targets the broader polymer family including LDPE, HDPE, and PET, with ambitions to scale to a size comparable to the existing business.
Egypt Facility and Capacity Details
The Egypt manufacturing facility remains a central pillar of the company's international growth strategy. The plant is expected to commence commercial operations in Q3 FY27 and is being set up with a capacity of approximately 60,000 metric tonnes per annum, similar to the Unit 2 facility in India. Management indicated that approximately 10% of FY27 consolidated topline is expected to come from Egypt, with the remaining 90% from Indian operations. Revenue from Egypt at peak utilization is estimated at more than INR 600 crore, with a potential of around INR 300 crore over a period of three years. The breakeven utilization level for the Egypt plant is approximately 30%–35%. Sales from the Egypt facility are expected to be split 50% from Egypt's domestic market and 50% from global markets, with a focus on North and South American markets through Qualified Industrial Zones (QIZ) and Free Trade Agreements (FTA). The Egypt plant's primary product focus will be stabilizers, CPVC additives, and metallic soaps.
On domestic capacity, Unit 1 has an installed capacity of approximately 25,000 tonnes, while Unit 2 has a capacity of approximately 60,000 tonnes. The CPVC facility at Palghar is currently operating at 70%–80% utilization. The company also absorbed an exceptional net loss of Rs. 0.52 crore related to a fire incident at its Palghar subsidiary facility in July 2025.
| Parameter: | Details |
|---|---|
| Egypt Plant Capacity: | ~60,000 MT per annum |
| Expected Commercial Operations: | Q3 FY27 |
| Egypt Revenue Potential (3 years): | ~INR 300 crore |
| Egypt Revenue Potential (Peak): | >INR 600 crore |
| Egypt Breakeven Utilization: | ~30%–35% |
| Egypt Sales Split: | 50% domestic, 50% global |
| Unit 1 Capacity (India): | ~25,000 tonnes |
| Unit 2 Capacity (India): | ~60,000 tonnes |
| Palghar CPVC Utilization: | 70%–80% |
Strategic Growth Outlook
Management reiterated its growth ambitions, targeting more than 40% revenue growth in FY27 and a 35% CAGR from FY26 to FY29. This growth strategy is underpinned by the commissioning and ramp-up of the Egypt manufacturing facility expected by Q3 FY27, higher utilization at the expanded Palghar facility, continued innovation in sustainable and value-added products, and new product introductions including oleo chemicals and products for polymers such as LLDPE, LDPE, HDPE, and PET. Management guided for EBITDA margins in the range of 13%–15% going forward. On raw material management, management noted that geopolitical volatility caused a temporary rise in raw material prices in March, and the company built higher-than-normal inventory levels covered through May, with ongoing price pass-through mechanisms in place. No CapEx plans for manufacturing in Europe or the United States have been finalized, though management stated it is studying the US market. The life sciences division is also expected to begin contributing to revenues during the current year.
Historical Stock Returns for Platinum Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.10% | -0.60% | -3.26% | -19.07% | -15.60% | +0.45% |
How might escalating geopolitical tensions or supply chain disruptions impact Platinum Industries' ability to ramp up the Egypt facility on schedule and achieve its targeted 10% contribution to FY27 consolidated revenue?
Given that CPVC gross margins have already improved from 6-7% to 18-20%, what competitive pressures from domestic and international players could limit further margin expansion toward the targeted 22%?
With the oleo chemicals segment targeting INR 55-60 crore in its first year under a CDMO model, how sustainable is this revenue stream if key CDMO clients internalize production or shift to alternative suppliers?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
